Depo Provera

From Anvita Health Wiki

Contents 1 Indications 2 Dosage 3 Adverse-effects 4 More General Terms 5 References

Indications

• contraceptive
• endometriosis

Dosage

• 150 mg IM# every 3 months*

• # Depo-subQ Provera-104 approved for SQ injection [5]
• * abstain from intercourse for 7 days may be initiated at any time during the menstrual cycle no data on harm to fetus if initiated during pregnancy [4]
• Injection: ( suspension) 150 mg/mL (1 mL); 400 mg/mL (2.5 & 10 mL).

Adverse-effects

• see medroxyprogesterone ( Provera)
• bone loss with Depo- Provera [1]

• only partially reversible [3]

• increased risk of sexually transmitted disease with Depo Provera [2]
  
• drug adverse effects of hormonal contraception

More General Terms

• pharmacologic combination
• contraceptive

References

1. Journal Watch 21(21):173, 2001 Berenson et al Obstet Gynecol 98:576, 2001
2. Journal Watch 24(19):149, 2004 Morrison CS et al, Hormonal conraceptive use, cervical ectopy and the acquisition of cervical infection, Sex Transm Dis 31:561, 2004
3. Prescriber's Letter 12(1): 2005 Depo-Provera (Medroxyprogesterone Injectable Suspension) and Bone Loss Detail-Document#: [1] (subscription needed) [2]
4. Journal Watch 25(8):66-67, 2005 Sneed R, Westhoff C, Morroni C, Tiezzi L. A prospective study of immediate initiation of depo medroxyprogesterone acetate contraceptive injection. Contraception. 2005 Feb;71(2):99-103. PMID: [3]
5. Prescriber's Letter 12(5): 2005 New Formulation: Depo-subQ Provera 104 Detail-Document#: [4] (subscription needed) [5]

Depo-Provera